Discrepancy between plasma and lung angiotensin-converting enzyme activity in experimental congestive heart failure. A novel aspect of endothelium dysfunction.

The renin-angiotensin and cardiac natriuretic systems play an important role in the pathophysiology of congestive heart failure (CHF). The status of the membrane-bound pulmonary and renal activities of three ectoenzymes involved in the regulation of these systems-angiotensin-converting enzyme (ACE), neutral endopeptidase (NEP), and aminopeptidase A (APA)-was investigated in Wistar rats 3 months after induction of myocardial infarction (MI) and in sham-operated (control) rats. Plasma renin activity and ACE activity, plasma angiotensin II (Ang II) levels, and atrial natriuretic factor levels were simultaneously determined. The lung ACE activity was decreased in MI rats compared with control rats (P < .0001), and this decrease depended on the severity of the heart failure. In contrast, plasma ACE activity was increased in MI rats (P < .01), and this increase was also proportional to the severity of MI. Northern blot analysis showed that the lung ACE mRNA level in severe MI rats was half that of the control rats. Renal ACE activity of the MI rats was not affected, and neither renal or pulmonary NEP nor pulmonary APA activities were altered. Thus, lung ACE gene expression appears to be both organ- and enzyme-specifically regulated during CHF. Whereas plasma renin was increased in heart failure rats, plasma Ang II levels were not different from those of control rats. Thus, decreased lung ACE activity could possibly contribute to keeping plasma Ang II levels in the normal range. The decrease in lung ACE activity and mRNA levels, combined with increased plasma ACE activity, represents a novel aspect of endothelial dysfunction in CHF.(ABSTRACT TRUNCATED AT 250 WORDS)

[1]  B. Greenberg,et al.  Diminished endothelium-derived relaxing factor activity in an experimental model of chronic heart failure. , 1991, Circulation research.

[2]  E. Kranias,et al.  Phosphorylation and functional modifications of sarcoplasmic reticulum and myofibrils in isolated rabbit hearts stimulated with isoprenaline. , 1985, The Biochemical journal.

[3]  N. B. Olivier,et al.  Heart failure depresses endothelium-dependent responses in canine femoral artery. , 1989, The American journal of physiology.

[4]  P Corvol,et al.  Two putative active centers in human angiotensin I-converting enzyme revealed by molecular cloning. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[5]  B. Fanburg,et al.  Hormonal influence on endothelial cell angiotensin-converting enzyme activity. , 1984, The American journal of physiology.

[6]  R. Solaro,et al.  Estimating the Functional Capabilities of Sarcoplasmic Reticulum in Cardiac Muscle , 1974, Circulation research.

[7]  R. Skidgel,et al.  Neutral endopeptidase 24.11 (enkephalinase) and related regulators of peptide hormones 1 , 1989, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[8]  R. Solaro,et al.  Coordination of cardiac myofibrillar and sarcotubular activities in rats exercised by swimming. , 1984, The American journal of physiology.

[9]  I. Grupp,et al.  Cardiac myosin heavy chain mRNA expression and myocardial function in the mouse heart. , 1991, Circulation research.

[10]  D W Cushman,et al.  Spectrophotometric assay and properties of the angiotensin-converting enzyme of rabbit lung. , 1971, Biochemical pharmacology.

[11]  I. Édes,et al.  Changes in Phosphoinositide Turnover in Isolated Guinea Pig Hearts Stimulated With Isoproterenol , 1989, Circulation research.

[12]  D. Ganten,et al.  Selective activation of cardiac angiotensinogen gene expression in post-infarction ventricular remodeling in the rat. , 1993, Journal of molecular and cellular cardiology.

[13]  J. Michel,et al.  Measurement of angiotensin II concentration in rat plasma: pathophysiological applications. , 1989, Clinical and experimental hypertension. Part A, Theory and practice.

[14]  Andrew,et al.  Atrial natriuretic factor in normal subjects and heart failure patients. Plasma levels and renal, hormonal, and hemodynamic responses to peptide infusion. , 1986, The Journal of clinical investigation.

[15]  H. Schunkert,et al.  Evidence for tissue-specific activation of renal angiotensinogen mRNA expression in chronic stable experimental heart failure. , 1992, The Journal of clinical investigation.

[16]  L. Jones,et al.  Isoproterenol-induced phosphorylation of a 15-kilodalton sarcolemmal protein in intact myocardium. , 1985, The Journal of biological chemistry.

[17]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[18]  G. Proetzel,et al.  Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease , 1992, Nature.

[19]  J. Michel,et al.  Hormonal and Cardiac Effects of Converting Enzyme Inhibition in Rat Myocardial Infarction , 1988, Circulation research.

[20]  E. Kranias.  Regulation of Ca2+ transport by cyclic 3',5'-AMP-dependent and calcium-calmodulin-dependent phosphorylation of cardiac sarcoplasmic reticulum. , 1985, Biochimica et biophysica acta.

[21]  J. Cohn,et al.  The neurohumoral axis in congestive heart failure. , 1984, Annals of internal medicine.

[22]  J. Michel,et al.  Low angiotensinogen levels are related to the severity and liver dysfunction of congestive heart failure: implications for renin measurements. , 1991, The American journal of medicine.

[23]  G Grupp,et al.  Comparison of normal, hypodynamic, and hyperdynamic mouse hearts using isolated work-performing heart preparations. , 1993, The American journal of physiology.

[24]  A. Fabiato,et al.  Relaxing and inotropic effects of cyclic AMP on skinned cardiac cells , 1975, Nature.

[25]  I. Grupp,et al.  Isolated Heart Preparations Perfused or Superfused with Balanced Salt Solutions , 1984 .

[26]  S. Kakiuchi,et al.  Effects of phospholamban phosphorylation catalyzed by adenosine 3':5'-monophosphate- and calmodulin-dependent protein kinases on calcium transport ATPase of cardiac sarcoplasmic reticulum. , 1983, Journal of molecular and cellular cardiology.

[27]  E. Silverstein,et al.  Induction of angiotensin converting enzyme in human monocytes in culture. , 1978, Biochemical and biophysical research communications.

[28]  D. Borchman,et al.  Proteolytic activation of the canine cardiac sarcoplasmic reticulum calcium pump. , 1986, Biochemistry.

[29]  N. Trippodo,et al.  Increased ANF secretion after volume expansion is preserved in rats with heart failure. , 1988, The American journal of physiology.

[30]  P. Karczewski,et al.  Differential sensitivity to isoprenaline of troponin I and phospholamban phosphorylation in isolated rat hearts. , 1990, The Biochemical journal.

[31]  Y. Sagara,et al.  Comparative studies of cardiac and skeletal sarcoplasmic reticulum ATPases. Effect of a phospholamban antibody on enzyme activation by Ca2+. , 1993, The Journal of biological chemistry.

[32]  E. Kranias,et al.  Phosphorylation of troponin I and phospholamban during catecholamine stimulation of rabbit heart , 1982, Nature.

[33]  M. Fishbein,et al.  Experimental myocardial infarction in the rat: qualitative and quantitative changes during pathologic evolution. , 1978, The American journal of pathology.

[34]  M. Fournié-Zaluski,et al.  Neutral endopeptidase 24.11: structure, inhibition, and experimental and clinical pharmacology. , 1993, Pharmacological reviews.

[35]  Philippe Amouyel,et al.  Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction , 1992, Nature.

[36]  Ha Won Kim,et al.  Mouse phospholamban gene expression during development in vivo and in vitro. , 1992, Circulation research.

[37]  Ha Won Kim,et al.  Functional reconstitution of the cardiac sarcoplasmic reticulum Ca2(+)-ATPase with phospholamban in phospholipid vesicles. , 1990, The Journal of biological chemistry.

[38]  H. Abe,et al.  Transient state kinetic studies of Ca2+-dependent ATPase and calcium transport by cardiac sarcoplasmic reticulum. Effect of cyclic AMP-dependent protein kinase-catalyzed phosphorylation of phospholamban. , 1980, The Journal of biological chemistry.

[39]  J. H. Wang,et al.  Dependence of cardiac sarcoplasmic reticulum calcium pump activity on the phosphorylation status of phospholamban. , 1991, The Journal of biological chemistry.

[40]  O. Costerousse,et al.  Angiotensin I-converting enzyme in human circulating mononuclear cells: genetic polymorphism of expression in T-lymphocytes. , 1993, The Biochemical journal.

[41]  T. Rector,et al.  Endothelium‐Dependent Vasodilation Is Attenuated in Patients With Heart Failure , 1991, Circulation.

[42]  A. Martonosi,et al.  SARCOPLASMIC RETICULUM. I. THE UPTAKE OF CA++ BY SARCOPLASMIC RETICULUM FRAGMENTS. , 1964, The Journal of biological chemistry.

[43]  J. Schwartz,et al.  Enkephalinase activity in rat peripheral organs. , 1981, European journal of pharmacology.

[44]  J. Schwartz,et al.  Distribution of enkephalinase (membrane metalloendopeptidase, E.C. 3.4.24.11) in rat organs. Detection using a monoclonal antibody. , 1988, Laboratory investigation; a journal of technical methods and pathology.

[45]  A. M. Watanabe,et al.  Phosphorylation of phospholamban in intact myocardium. Role of Ca2+-calmodulin-dependent mechanisms. , 1985, The Journal of biological chemistry.

[46]  C. Johnston,et al.  INCREASED CARDIAC ANGIOTENSIN‐CONVERTING ENZYME IN RATS WITH CHRONIC HEART FAILURE , 1990, Clinical and experimental pharmacology & physiology.

[47]  B. Seegal,et al.  Angiotensin-converting enzyme: vascular endothelial localization. , 1976, Science.

[48]  I. Édes,et al.  Intracellular mechanisms mediating reversal of beta-adrenergic stimulation in intact beating hearts. , 1993, The American journal of physiology.

[49]  J. H. Collins,et al.  Sequence analysis of phospholamban. Identification of phosphorylation sites and two major structural domains. , 1986, The Journal of biological chemistry.

[50]  F. Matsuzaki,et al.  Increased levels of serum angiotensin-converting enzyme activity in hyperthyroidism. , 1982, Annals of internal medicine.

[51]  S. Oparil,et al.  Altered angiotensin-converting enzyme in lung and extrapulmonary tissues of hypoxia-adapted rats. , 1988, Journal of applied physiology.

[52]  J. Michel,et al.  Urinary cyclic guanosine monophosphate as an indicator of experimental congestive heart failure in rats. , 1990, Cardiovascular research.

[53]  L. Wei,et al.  Expression and characterization of recombinant human angiotensin I-converting enzyme. Evidence for a C-terminal transmembrane anchor and for a proteolytic processing of the secreted recombinant and plasma enzymes. , 1991, The Journal of biological chemistry.

[54]  D. Hathaway,et al.  beta-Adrenergic stimulation of phospholamban phosphorylation and Ca2+-ATPase activity in guinea pig ventricles. , 1983, The Journal of biological chemistry.

[55]  K. Margulies,et al.  Cardiorenal actions of neutral endopeptidase inhibition in experimental congestive heart failure. , 1990, Circulation.

[56]  M. Pfeffer,et al.  Myocardial Infarct Size and Ventricular Function in Rats , 1979, Circulation research.

[57]  E. Kranias,et al.  Mechanism of the stimulation of calcium ion dependent adenosine triphosphatase of cardiac sarcoplasmic reticulum by adenosine 3',5'-monophosphate dependent protein kinase. , 1980, Biochemistry.

[58]  C. Lloyd,et al.  Induction by glucocorticoids of angiotensin converting enzyme production from bovine endothelial cells in culture and rat lung in vivo. , 1982, The Journal of clinical investigation.

[59]  E. Kranias,et al.  Regulation of the skeletal sarcoplasmic reticulum Ca2+ pump by phospholamban in reconstituted phospholipid vesicles. , 1990, Membrane biochemistry.

[60]  A. Katz,et al.  Mechanism by which Cyclic Adenosine 3′:5′‐Monophosphate‐Dependent Protein Kinase Stimulates Calcium Transport in Cardiac Sarcoplasmic Reticulum , 1979, Circulation research.

[61]  J. P. Lindemann.  Alpha-adrenergic stimulation of sarcolemmal protein phosphorylation and slow responses in intact myocardium. , 1986, The Journal of biological chemistry.

[62]  Salim Yusuf,et al.  Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. , 1991, The New England journal of medicine.

[63]  J. H. Wang,et al.  Phospholamban regulation of cardiac sarcoplasmic reticulum (Ca(2+)-Mg2+)-ATPase. Mechanism of regulation and site of monoclonal antibody interaction. , 1991, The Journal of biological chemistry.

[64]  O. H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[65]  M. Inui,et al.  Molecular mechanism of regulation of Ca2+ pump ATPase by phospholamban in cardiac sarcoplasmic reticulum. Effects of synthetic phospholamban peptides on Ca2+ pump ATPase. , 1992, The Journal of biological chemistry.

[66]  Mario R. Capecchi,et al.  Disruption of the proto-oncogene int-2 in mouse embryo-derived stem cells: a general strategy for targeting mutations to non-selectable genes , 1988, Nature.

[67]  J. Richalet,et al.  Effects of propranolol and pindolol on plasma ANP levels in humans at rest and during exercise. , 1989, The American journal of physiology.

[68]  Y. Agid,et al.  Enkephalin Dipeptidyl Carboxypeptidase (Enkephalinase) Activity: Selective Radioassay, Properties, and Regional Distribution in Human Brain , 1982, Journal of neurochemistry.

[69]  J. Ménard,et al.  Measurement of renin activity, concentration and substrate in rat plasma by radioimmunoassay of angiotensin I. , 1972, Endocrinology.

[70]  T. Hewett,et al.  Alpha-skeletal actin is associated with increased contractility in the mouse heart. , 1994, Circulation research.

[71]  R. Zelis,et al.  Alterations in vasomotor tone in congestive heart failure. , 1982, Progress in cardiovascular diseases.

[72]  E. Kranias,et al.  Phosphorylation of C-protein, troponin I and phospholamban in isolated rabbit hearts. , 1988, The Biochemical journal.

[73]  P. Corvol,et al.  Identification and characterization of neutral endopeptidase in endothelial cells from venous or arterial origins. , 1992, The Journal of biological chemistry.

[74]  L. Jones,et al.  Purification and complete sequence determination of the major plasma membrane substrate for cAMP-dependent protein kinase and protein kinase C in myocardium. , 1991, The Journal of biological chemistry.

[75]  H. Schunkert,et al.  Tissue-specific activation of cardiac angiotensin converting enzyme in experimental heart failure. , 1991, Circulation research.

[76]  U. Ryan,et al.  Localization of angiotensin converting enzyme (kininase II). I. Preparation of antibody-hemeoctapeptide conjugates. , 1976, Tissue & cell.

[77]  E. Carafoli,et al.  Nature and site of phospholamban regulation of the Ca2+ pump of sarcoplasmic reticulum , 1989, Nature.